XML 14 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
ASSETS    
Cash and cash equivalents $ 144,583 $ 13,414
Short-term investments 27,796 37,724
Accounts receivable, net 41,874 1,960
Inventory 10,108 5,340
Prepaid expenses and other current assets 3,702 3,705
Total current assets 228,063 62,143
Property and equipment, net 5,981 5,076
Other assets 263 263
Total assets 234,307 67,482
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)    
Accounts payable 18,769 6,814
Accrued clinical liabilities 26,920 13,207
Accrued payroll and employee liabilities 8,860 8,414
Other accrued liabilities 17,175 6,288
Deferred revenue 2,763 1,099
Promissory note payable to related party 25,000
Convertible notes payable to related parties, net of discount 3,684 2,911
Total current liabilities 103,171 38,733
Promissory note payable to related party, non-current 50,000
Total liabilities 103,171 88,733
Commitments and contingencies (see Note 5)
Stockholders’ equity (deficit):    
Preferred stock, $0.01 par value: 2,500 shares authorized; no shares issued or outstanding at December 31, 2017 and 2016
Common stock, $0.01 par value: 100,000 shares authorized; 64,609 and 39,355 shares issued and outstanding at December 31, 2017 and 2016, respectively 646 394
Additional paid-in capital 913,955 564,343
Accumulated other comprehensive loss (10) (17)
Accumulated deficit (783,455) (585,971)
Total stockholders’ equity (deficit) 131,136 (21,251)
Total liabilities and stockholders’ equity (deficit) $ 234,307 $ 67,482